scutellarin has been researched along with Infarction, Middle Cerebral Artery in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Li, D; Li, S; Li, Y | 1 |
| Hongyun, H; Liqiang, Y; Pengyue, Z; Tao, G; Yihao, D | 1 |
| Chen, Z; Dong, L; Jiang, Q; Li, X; Wang, Y; Wu, X; Zhang, G; Zhen, Y | 1 |
| Chen, XL; Liu, JX; Liu, Y; Qian, YH; Song, TS; Zhao, JJ | 1 |
| Lin, LL; Liu, AJ; Liu, JG; Qin, LP; Su, DF; Yu, XH | 1 |
| Deng, X; Liu, X; Liu, Y; Shi, J; Wang, C; Yan, X; Zhang, Y | 1 |
| Chen, HL; Han, H; Jia, WJ; Li, F; Li, HE; Li, JJ; Wu, CY; Yuan, Y; Zhang, XL | 1 |
| Fan, G; Liang, W; Liu, G; Tang, G; Wang, Y; Wang, Z; Xu, W; Zhao, M | 1 |
| Chen, LM; Gao, HM; Gong, LL; Liang, RX; Liu, XQ; Ma, XJ; Wang, L; Wang, ZM; Yin, XJ | 1 |
| Ling, EA; Rangarajan, P; Wu, C; Yuan, Y; Zha, H | 1 |
| Kan, EM; Ling, EA; Rangarajan, P; Wu, C; Wu, Y; Yuan, Y | 1 |
| Fang, M; Ling, EA; Lu, J; Rangarajan, P; Wang, H; Wu, C; Wu, Y; Yuan, Y | 1 |
| Han, J; Ma, X; Pan, Q; Ren, H; Wang, W; Zheng, C; Zheng, Q; Zhou, M | 1 |
| Chen, T; Gong, Z; Hu, J; Lan, Y; Li, Y; Liu, T; Lu, Y; Mi, L; Wang, A; Wang, Y; Yang, W; Zheng, J | 1 |
| Hu, XM; Wang, LX; Xu, SQ; Zeng, FD; Zhang, HF | 1 |
| Cheng, C; Liu, Q; Lu, J; Luo, G; Wang, Y; Yang, P; Zhao, X | 1 |
| Gao, XM; Guo, H; Hu, LM; Kang, LY; Li, H; Liu, Y; Shi, F; Wang, SX; Wang, YL | 1 |
| Fu, Y; Li, NG; Qian, L; Shen, M; Shi, Q; Tang, H; Tang, Y; Zhang, L | 1 |
| Hu, XM; Zeng, FD; Zhou, MM | 1 |
19 other study(ies) available for scutellarin and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Breviscapine Alleviates Cognitive Impairments Induced by Transient Cerebral Ischemia/Reperfusion through Its Anti-Inflammatory and Anti-Oxidant Properties in a Rat Model.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Brain Ischemia; China; Cognitive Dysfunction; Flavonoids; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury | 2020 |
Breviscapine confers a neuroprotective efficacy against transient focal cerebral ischemia by attenuating neuronal and astrocytic autophagy in the penumbra.
Topics: Animals; Astrocytes; Autophagy; Beclin-1; Brain; Brain Ischemia; Disease Models, Animal; Flavonoids; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Neurons; Neuroprotection; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke | 2017 |
Vitexin protects brain against ischemia/reperfusion injury via modulating mitogen-activated protein kinase and apoptosis signaling in mice.
Topics: Animals; Apigenin; Apoptosis; bcl-2-Associated X Protein; Brain Ischemia; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Infarction, Middle Cerebral Artery; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Mice; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Reperfusion Injury | 2015 |
Breviscapine improves functions of spatial learning and memory of focal cerebral ischemia rats.
Topics: Animals; Brain Ischemia; Cerebral Cortex; Disease Models, Animal; Erigeron; Flavonoids; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Male; Maze Learning; Memory; Neuroprotective Agents; Plants, Medicinal; Random Allocation; Rats; Rats, Sprague-Dawley; Spatial Behavior | 2009 |
Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats.
Topics: Animals; Apigenin; Apoptosis; Brain Ischemia; Cardiotonic Agents; Dose-Response Relationship, Drug; Drug Combinations; Flavonoids; Glucuronates; Infarction, Middle Cerebral Artery; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Toxicity Tests, Acute | 2007 |
Scutellarin Alleviates Ischemic Brain Injury in the Acute Phase by Affecting the Activity of Neurotransmitters in Neurons.
Topics: Animals; Brain Injuries; Brain Ischemia; Infarction, Middle Cerebral Artery; Molecular Docking Simulation; Neurons; Neurotransmitter Agents; Rats; Reperfusion Injury; Stroke | 2023 |
Scutellarin Exerts Anti-Inflammatory Effects in Activated Microglia/Brain Macrophage in Cerebral Ischemia and in Activated BV-2 Microglia Through Regulation of MAPKs Signaling Pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apigenin; Cerebral Cortex; Gene Expression Regulation; Glucuronates; Imidazoles; Infarction, Middle Cerebral Artery; Inflammation Mediators; Macrophage Activation; Male; MAP Kinase Signaling System; Mice; Microglia; Nerve Tissue Proteins; Nitric Oxide Synthase Type II; Protein Kinases; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2020 |
PK-PD Correlation of Erigeron Breviscapus Injection in the Treatment of Cerebral Ischemia-Reperfusion Injury Model Rats.
Topics: Animals; Apigenin; Chromatography, High Pressure Liquid; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Erigeron; Glucuronates; Infarction, Middle Cerebral Artery; Injections, Intravenous; Male; Molecular Structure; Phytotherapy; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2021 |
[Protective effect and mechanism of scutellarin ethyl ester on focal cerebral ischemia induced by ligation of middle cerebral artery in rats].
Topics: Animals; Apigenin; Brain Ischemia; Glucuronates; Infarction, Middle Cerebral Artery; Male; Middle Cerebral Artery; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2017 |
Anti-inflammatory effects of Edaravone and Scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV-2 microglia.
Topics: Animals; Anti-Inflammatory Agents; Antipyrine; Apigenin; Brain; Brain Ischemia; Cell Count; Cell Line; Cell Survival; Cytokines; Disease Models, Animal; Edaravone; Glucuronates; Infarction, Middle Cerebral Artery; Lipopolysaccharides; Male; Microglia; Nitric Oxide; Nitric Oxide Synthase Type II; Random Allocation; Rats, Sprague-Dawley; Reactive Oxygen Species | 2014 |
Scutellarin regulates the Notch pathway and affects the migration and morphological transformation of activated microglia in experimentally induced cerebral ischemia in rats and in activated BV-2 microglia.
Topics: Actins; Animals; Apigenin; Cell Adhesion; Cell Line, Transformed; Cell Movement; Cerebrum; Disease Models, Animal; Dose-Response Relationship, Drug; Glucuronates; Infarction, Middle Cerebral Artery; Lipopolysaccharides; Male; Microglia; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Receptors, Notch; rho GTP-Binding Proteins; Signal Transduction; Tumor Necrosis Factor-alpha | 2015 |
Scutellarin regulates microglia-mediated TNC1 astrocytic reaction and astrogliosis in cerebral ischemia in the adult rats.
Topics: Animals; Anti-Inflammatory Agents; Apigenin; Astrocytes; Brain Ischemia; Cell Line; Cell Survival; Cerebral Cortex; Disease Models, Animal; Gliosis; Glucuronates; Infarction, Middle Cerebral Artery; Male; Mice; Microglia; Neuroprotective Agents; Rats, Sprague-Dawley | 2015 |
Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor.
Topics: Animals; Apigenin; Brain; Brain Ischemia; Disease Models, Animal; Down-Regulation; Glucuronates; Infarction, Middle Cerebral Artery; Interleukin-1beta; Interleukin-6; Neuroprotective Agents; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha | 2016 |
Pharmacokinetic Comparison of Scutellarin and Paeoniflorin in Sham-Operated and Middle Cerebral Artery Occlusion Ischemia and Reperfusion Injury Rats after Intravenous Administration of Xin-Shao Formula.
Topics: Animals; Apigenin; Disease Models, Animal; Glucosides; Glucuronates; Infarction, Middle Cerebral Artery; Male; Medicine, Chinese Traditional; Monoterpenes; Plant Extracts; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke | 2016 |
Protective effects of scutellarin against cerebral ischemia in rats: evidence for inhibition of the apoptosis-inducing factor pathway.
Topics: Animals; Apigenin; Apoptosis; Apoptosis Inducing Factor; Biological Transport; Brain; Brain Ischemia; Cell Nucleus; DNA Fragmentation; Erigeron; Glucuronates; Infarction, Middle Cerebral Artery; Male; Mitochondria; NAD; Neuroprotective Agents; Phytotherapy; Plant Extracts; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley | 2009 |
PEG-scutellarin prodrugs: synthesis, water solubility and protective effect on cerebral ischemia/reperfusion injury.
Topics: Animals; Apigenin; Disease Models, Animal; Drug Evaluation, Preclinical; Glucuronates; Infarction, Middle Cerebral Artery; Molecular Structure; Molecular Weight; Polyethylene Glycols; Prodrugs; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Solubility; Stereoisomerism; Water | 2010 |
Neuroprotective effects of scutellarin against hypoxic-ischemic-induced cerebral injury via augmentation of antioxidant defense capacity.
Topics: Animals; Antioxidants; Apigenin; Brain Infarction; Cerebral Cortex; Drugs, Chinese Herbal; Glucuronates; Hypoxia-Ischemia, Brain; Infarction, Middle Cerebral Artery; Male; Neurons; Neuroprotective Agents; Oxidative Stress; Primary Cell Culture; Rats; Rats, Wistar; Reactive Oxygen Species | 2011 |
Synthesis and protective effect of scutellarein on focal cerebral ischemia/reperfusion in rats.
Topics: Animals; Apigenin; Brain Ischemia; Glucuronates; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Rats; Reperfusion Injury | 2012 |
Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion.
Topics: Animals; Apigenin; Blood-Brain Barrier; Brain; Brain Ischemia; Erigeron; Fibroblast Growth Factor 2; Glucuronates; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vascular Endothelial Growth Factor A | 2005 |